Showing posts with label metastatic medullary thyroid cancer (MTC). Show all posts
Showing posts with label metastatic medullary thyroid cancer (MTC). Show all posts
Monday, September 3, 2012

Exelixis reports data from cabozantinib phase 3 trial on MTC

›
Exelixis, Inc. reported data from the phase 3 pivotal trial of cabozantinib in patients with progressive, unresectable, l...